Advisor Group Holdings, Inc. Supernus Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

$67.1 Billion
Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 36,940 shares of SUPN stock, worth $1.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,940

Previous 1,956 1788.55%

Holding current value

$1.66 Million

Previous $61,000 2793.44%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$31.45 - $47.79 $1.1 Million - $1.67 Million	34,984 Added 1788.55%	36,940 $1.77 Million
Q2 2025 Sep 04, 2025	SELL	$30.29 - $33.43 $726 - $802	-24 Reduced 1.21%	1,956 $61,000
Q2 2025 Aug 13, 2025	BUY	$30.29 - $33.43 $40,952 - $45,197	1,352 Added 215.29%	1,980 $62,000
Q1 2025 May 12, 2025	SELL	$31.17 - $40.0 $15,959 - $20,480	-512 Reduced 44.91%	628 $20,000
Q4 2024 Jun 06, 2025	BUY	$31.89 - $37.83 $15,753 - $18,688	494 Added 78.66%	1,122 $40,000
Q4 2024 Feb 07, 2025	BUY	$31.89 - $37.83 $350 - $416	11 Added 0.97%	1,140 $41,000
Q3 2024 Nov 13, 2024	BUY	$25.77 - $35.16 $1,082 - $1,476	42 Added 3.86%	1,129 $35,000
Q2 2024 Aug 13, 2024	SELL	$25.99 - $33.85 $56,866 - $74,063	-2,188 Reduced 66.81%	1,087 $29,000
Q1 2024 May 10, 2024	SELL	$27.11 - $35.17 $171,741 - $222,801	-6,335 Reduced 65.92%	3,275 $111,000
Q4 2023 Feb 12, 2024	SELL	$22.72 - $29.68 $72,885 - $95,213	-3,208 Reduced 25.03%	9,610 $278,000
Q3 2023 Nov 13, 2023	BUY	$27.57 - $32.91 $123,954 - $147,963	4,496 Added 54.03%	12,818 $353,000
Q2 2023 Aug 10, 2023	BUY	$29.91 - $38.73 $2,123 - $2,749	71 Added 0.86%	8,322 $250,000
Q1 2023 May 12, 2023	SELL	$34.93 - $42.03 $3,283 - $3,950	-94 Reduced 1.13%	8,251 $298,000
Q4 2022 Feb 10, 2023	SELL	$31.09 - $37.88 $481,739 - $586,950	-15,495 Reduced 65.0%	8,345 $297,000
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $558,900 - $687,414	19,413 Added 438.51%	23,840 $806,000
Q2 2022 Aug 10, 2022	BUY	$25.33 - $34.25 $4,280 - $5,788	169 Added 3.97%	4,427 $127,000
Q1 2022 May 04, 2022	BUY	$28.51 - $32.9 $6,813 - $7,863	239 Added 5.95%	4,258 $138,000
Q3 2021 Nov 05, 2021	SELL	$23.54 - $31.39 $3,413 - $4,551	-145 Reduced 3.48%	4,019 $107,000
Q2 2021 Aug 02, 2021	BUY	$26.72 - $33.19 $4,515 - $5,609	169 Added 4.23%	4,164 $129,000
Q1 2021 May 13, 2021	BUY	$24.15 - $31.45 $60,713 - $79,065	2,514 Added 169.75%	3,995 $104,000
Q4 2020 Feb 10, 2021	SELL	$17.7 - $25.81 $47,436 - $69,170	-2,680 Reduced 64.41%	1,481 $38,000
Q3 2020 Nov 12, 2020	BUY	$20.2 - $25.05 $2,504 - $3,106	124 Added 3.07%	4,161 $87,000
Q2 2020 Aug 14, 2020	BUY	$17.09 - $24.89 $9,040 - $13,166	529 Added 15.08%	4,037 $95,000
Q1 2020 May 18, 2020	BUY	$14.45 - $24.69 $50,690 - $86,612	3,508 New	3,508 $63,000

Others Institutions Holding SUPN

# of Institutions

333

Shares Held

60.3M

Call Options Held

234K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.41B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Supernus Pharmaceuticals, Inc. Transaction History